A step forward towards cryoablation for early-stage breast cancer: Final 5-year results of the ICE3 trial

Researchers are consistently pushing back the boundaries of what is possible for the treatment of breast cancer. Results of one of the most exciting and innovative trials in breast cancer, the ICE3 Trial on cryoablation of early stage, low-risk breast cancer, were recently published in the Annals of Surgical Oncology by Dr. Richard Fine. In […]
Cancer in Kidney Transplant Patients – Occurrence Frequency & Treatment Options

Many kidney transplant patients are overcoming the immediate threat of kidney disease only to face the challenge of a cancer diagnosis. This has many implications but for those who face kidney cancer in their transplanted kidney, it’s essential to find a suitable treatment. For a kidney recipient who has only one kidney, cryoablation offers a […]
IceCure to Exhibit at European Conference on Interventional Oncology (ECIO) 2024 in Palma De Mallorca, Spain

IceCure Medical is excited to participate as a Silver Sponsor in the 2024 European Conference on Interventional Oncology (ECIO) Meeting in Palma De Mallorca, Spain on April 28 – May 1. We have an exciting program of events, including several hands on sessions and scientific poster presentations. IceCure representatives will be onsite to show you […]
IceCure to Exhibit at the 2024 American Society of Breast Surgeons (ASBrS) Annual Meeting in Orlando, Florida

IceCure Medical is excited to announce our participation in the 26 Annual Meeting of The American Society of Breast Surgeons (ASBrS), happening April 10 – 14 at Marriott Orlando World Center, Orlando Florida. This event presents a prime opportunity for experts to discover the innovative ProSense System for breast tumor cryoablation. We invite you to […]
Is cryo-immunology the next frontier for cryoablation?

Cryoablation represents a frontier in minimally invasive cancer treatment, offering a novel approach to the destruction of both benign and malignant tumors. This procedure leverages extreme cold, applied directly to the tumor site, to induce cell death without the need for traditional surgical removal. The appeal of cryoablation lies in its simplicity and the reduced […]
What We Learned About Cancer in 2023

The year 2023 marked a significant era in the journey of oncology. With the blend of advancements in technology, dedicated research, and an unwavering commitment from the scientific community, we gained new insights and made remarkable progress in understanding and combating cancer. Here we share the key developments in cancer research in 2023, starting from […]
IceCure to Exhibit at the Society of Interventional Radiology (SIO) 2024 Conference in Long Beach, CA

IceCure Medical is pleased to announce that we will be exhibiting at the upcoming Society of Interventional Oncology’s Annual Conference from January 25-28th. Our dedicated team will be present at Booth #312, ready to showcase the groundbreaking ProSense Cryoablation System for the treatment of benign and malignant tumors. Join us for live demonstrations and explore […]
Case Study: Embolization & Percutaneous Cryoablation to Treat Vertebral Metastasis for Pain Palliation

Discover how cryoablation and embolization can effectively treat complex vertebral masses and provide pain palliation in one session.
IceCure to Exhibit at the European Society of Breast Imaging (EUSOBI) 2023 Conference in Valencia, Spain

IceCure Medical is thrilled to be exhibiting at the 2023 European Society of Breast Imaging Conference in Valencia, Spain from September 28 – 30, 2023. Visit the Booth R07 to meet with the IceCure team and learn more about the ProSense Cryoablation System for the treatment of benign and cancerous breast tumors. Learn about the […]
IceCure to Exhibit at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 Conference in Copenhagen, Denmark

IceCure Medical is thrilled to be exhibiting at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 Conference in Copenhagen, Denmark from September 9 – 13. We have fantastic events planned to highlight the benefits of the ProSense™ Cryoablation System including a symposium moderated by Professor Julien Frandon, MD, PhD and participation in the […]